» Authors » Ebtihal Y Alyusuf

Ebtihal Y Alyusuf

Explore the profile of Ebtihal Y Alyusuf including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 114
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyusuf E, Alhmayin L, Albasri E, Enani J, Altuwaijri H, Alsomali N, et al.
Front Endocrinol (Lausanne) . 2024 Feb; 15:1326134. PMID: 38405143
Background: Bethesda III and IV thyroid nodules continue to be difficult to manage. Although molecular testing may assist in decision-making, it is expensive, not widely available, and not without pitfalls....
2.
Jammah A, AlSadhan I, Alyusuf E, Alajmi M, Alhamoudi A, Al-Sofiani M
Front Endocrinol (Lausanne) . 2023 Dec; 14:1256232. PMID: 38047113
Background: Studies have reported differing factors associated with poor outcomes in patients with differentiated thyroid cancer (DTC). We aimed to describe our 20 years of experience in the management of...
3.
Alsadhan I, Alyusuf E, Shaltoot O, AlRuwashid S, Alhamad M, Ekhzaimy A, et al.
Arch Osteoporos . 2022 Dec; 18(1):16. PMID: 36576607
Purpose: To investigate the efficacy and feasibility of telemedicine care in osteoporotic patients during the COVID-19 lockdown period in Saudi Arabia compared to in-person patients, as well as their satisfaction...
4.
Al-Qahtani K, Aldeeri I, Alshaibi A, Alshabib N, Barghouthi R, Alyusuf E, et al.
Thyroid . 2022 Jun; 32(9):1029-1036. PMID: 35708106
Fasting during Ramadan may be challenging for patients on levothyroxine (LT4), as the drug has a narrow therapeutic index and is administered on an empty stomach. The majority of Muslims...
5.
Ekhzaimy A, Alyusuf E, Alswailem M, Alzahrani A
Medicina (Kaunas) . 2022 Feb; 58(2). PMID: 35208525
: Sclerostin is an gene product that inhibits osteoblast activity and prevents excessive bone formation by antagonizing the Wnt signaling pathway. Sclerosteosis has been linked to loss of function mutations...
6.
Alyusuf E, Alharthi S, Alguwaihes A, Jammah A, Alfadda A, Al-Sofiani M
Diabetes Metab Syndr . 2022 Feb; 16(2):102416. PMID: 35150962
Background And Aims: To identify predictors of use and benefit from continuous glucose monitoring (CGM) in people with type 1 diabetes (T1D). Methods: Predictors of CGM use and changes in...
7.
Alyusuf E, Ekhzaimy A, Rivera J
AACE Clin Case Rep . 2021 Jun; 7(2):153-157. PMID: 34095476
Objective: Insulinomas are rare, life-threatening pancreatic neuroendocrine tumors. Surgical removal continues to be the treatment of choice, yet it is associated with considerable risk of morbidity. Here, we describe our...
8.
Alguwaihes A, Sabico S, Hasanato R, Al-Sofiani M, Megdad M, Albader S, et al.
Aging Clin Exp Res . 2021 Mar; 33(5):1415-1422. PMID: 33788172
Purpose: As the world continues to cautiously navigate its way through the coronavirus disease 2019 (COVID-19) pandemic, several breakthroughs in therapies and vaccines are currently being developed and scrutinized. Consequently,...
9.
Alharthi S, Alyusuf E, Alguwaihes A, Alfadda A, Al-Sofiani M
Diabetes Res Clin Pract . 2021 Feb; 173:108682. PMID: 33539868
Background: To minimize the spread of Coronavirus Disease-2019, Saudi Arabia imposed a nationwide lockdown for over 6 weeks. We examined the impact of lockdown on glycemic control in individuals with...
10.
Al-Sofiani M, Alyusuf E, Alharthi S, Alguwaihes A, Al-Khalifah R, Alfadda A
J Diabetes Sci Technol . 2020 Aug; 15(2):329-338. PMID: 32762362
Background: The importance of telemedicine in diabetes care became more evident during the coronavirus disease 2019 (COVID-19) pandemic as many people with diabetes, especially those in areas without well-established telemedicine,...